List of Tables
Table 1. Global Biosimilar Insulin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Biosimilar Insulin Market Value by Distribution Channel (US$ Million), 2025 vs 2032
Table 3. Global Biosimilar Insulin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Biosimilar Insulin Sales (K Unit) of Key Manufacturers (2021–2026)
Table 5. Global Biosimilar Insulin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Biosimilar Insulin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Biosimilar Insulin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Biosimilar Insulin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Biosimilar Insulin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Biosimilar Insulin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Biosimilar Insulin, Product Types and Applications
Table 12. Global Key Manufacturers of Biosimilar Insulin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biosimilar Insulin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biosimilar Insulin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosimilar Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Biosimilar Insulin Sales by Region (K Unit), 2021–2026
Table 18. Global Biosimilar Insulin Sales Market Share by Region (2021–2026)
Table 19. Global Biosimilar Insulin Sales by Region (K Unit), 2027–2032
Table 20. Global Biosimilar Insulin Sales Market Share by Region (2027–2032)
Table 21. Global Biosimilar Insulin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Biosimilar Insulin Revenue Market Share by Region (2021–2026)
Table 23. Global Biosimilar Insulin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Biosimilar Insulin Revenue Market Share by Region (2027–2032)
Table 25. North America Biosimilar Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Biosimilar Insulin Sales by Country (K Unit), 2021–2026
Table 27. North America Biosimilar Insulin Sales by Country (K Unit), 2027–2032
Table 28. North America Biosimilar Insulin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Biosimilar Insulin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Biosimilar Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Biosimilar Insulin Sales by Country (K Unit), 2021–2026
Table 32. Europe Biosimilar Insulin Sales by Country (K Unit), 2027–2032
Table 33. Europe Biosimilar Insulin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Biosimilar Insulin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Biosimilar Insulin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Biosimilar Insulin Sales by Region (K Unit), 2021–2026
Table 37. Asia Pacific Biosimilar Insulin Sales by Region (K Unit), 2027–2032
Table 38. Asia Pacific Biosimilar Insulin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Biosimilar Insulin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Biosimilar Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Biosimilar Insulin Sales by Country (K Unit), 2021–2026
Table 42. Latin America Biosimilar Insulin Sales by Country (K Unit), 2027–2032
Table 43. Latin America Biosimilar Insulin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Biosimilar Insulin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Biosimilar Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Biosimilar Insulin Sales by Country (K Unit), 2021–2026
Table 47. Middle East and Africa Biosimilar Insulin Sales by Country (K Unit), 2027–2032
Table 48. Middle East and Africa Biosimilar Insulin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Biosimilar Insulin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Biosimilar Insulin Sales (K Unit) by Type (2021–2026)
Table 51. Global Biosimilar Insulin Sales (K Unit) by Type (2027–2032)
Table 52. Global Biosimilar Insulin Sales Market Share by Type (2021–2026)
Table 53. Global Biosimilar Insulin Sales Market Share by Type (2027–2032)
Table 54. Global Biosimilar Insulin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Biosimilar Insulin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Biosimilar Insulin Revenue Market Share by Type (2021–2026)
Table 57. Global Biosimilar Insulin Revenue Market Share by Type (2027–2032)
Table 58. Global Biosimilar Insulin Price (US$/Unit) by Type (2021–2026)
Table 59. Global Biosimilar Insulin Price (US$/Unit) by Type (2027–2032)
Table 60. Global Biosimilar Insulin Sales (K Unit) by Distribution Channel (2021–2026)
Table 61. Global Biosimilar Insulin Sales (K Unit) by Distribution Channel (2027–2032)
Table 62. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2021–2026)
Table 63. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2027–2032)
Table 64. Global Biosimilar Insulin Revenue (US$ Million) by Distribution Channel (2021–2026)
Table 65. Global Biosimilar Insulin Revenue (US$ Million) by Distribution Channel (2027–2032)
Table 66. Global Biosimilar Insulin Revenue Market Share by Distribution Channel (2021–2026)
Table 67. Global Biosimilar Insulin Revenue Market Share by Distribution Channel (2027–2032)
Table 68. Global Biosimilar Insulin Price (US$/Unit) by Distribution Channel (2021–2026)
Table 69. Global Biosimilar Insulin Price (US$/Unit) by Distribution Channel (2027–2032)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eli Lilly Biosimilar Insulin Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sanofi Biosimilar Insulin Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Gan&Lee Company Information
Table 81. Gan&Lee Description and Business Overview
Table 82. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Gan&Lee Biosimilar Insulin Product
Table 84. Gan&Lee Recent Developments/Updates
Table 85. Tonghua Dongbao Company Information
Table 86. Tonghua Dongbao Description and Business Overview
Table 87. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Tonghua Dongbao Biosimilar Insulin Product
Table 89. Tonghua Dongbao Recent Developments/Updates
Table 90. United Laboratory Company Information
Table 91. United Laboratory Description and Business Overview
Table 92. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. United Laboratory Biosimilar Insulin Product
Table 94. United Laboratory Recent Developments/Updates
Table 95. Geropharm Company Information
Table 96. Geropharm Description and Business Overview
Table 97. Geropharm Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Geropharm Biosimilar Insulin Product
Table 99. Geropharm Recent Developments/Updates
Table 100. Biocon Company Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Biocon Biosimilar Insulin Product
Table 104. Biocon Recent Developments/Updates
Table 105. Wockhardt Company Information
Table 106. Wockhardt Description and Business Overview
Table 107. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Wockhardt Biosimilar Insulin Product
Table 109. Wockhardt Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Biosimilar Insulin Distributors List
Table 113. Biosimilar Insulin Customers List
Table 114. Biosimilar Insulin Market Trends
Table 115. Biosimilar Insulin Market Drivers
Table 116. Biosimilar Insulin Market Challenges
Table 117. Biosimilar Insulin Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biosimilar Insulin
Figure 2. Global Biosimilar Insulin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Biosimilar Insulin Market Share by Type: 2025 & 2032
Figure 4. Biosimilar Insulin Glargine Product Picture
Figure 5. Biosimilar Insulin Lispro Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biosimilar Insulin Market Value by Distribution Channel (US$ Million), 2021–2032
Figure 8. Global Biosimilar Insulin Market Share by Distribution Channel: 2025 & 2032
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Global Biosimilar Insulin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Biosimilar Insulin Market Size (US$ Million), 2021–2032
Figure 14. Global Biosimilar Insulin Sales (K Unit), 2021–2032
Figure 15. Global Biosimilar Insulin Average Price (US$/Unit), 2021–2032
Figure 16. Biosimilar Insulin Report Years Considered
Figure 17. Biosimilar Insulin Sales Share by Manufacturers in 2025
Figure 18. Global Biosimilar Insulin Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Biosimilar Insulin Players: Market Share by Revenue in Biosimilar Insulin in 2025
Figure 20. Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Biosimilar Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Biosimilar Insulin Sales Market Share by Country (2021–2032)
Figure 23. North America Biosimilar Insulin Revenue Market Share by Country (2021–2032)
Figure 24. United States Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Biosimilar Insulin Sales Market Share by Country (2021–2032)
Figure 27. Europe Biosimilar Insulin Revenue Market Share by Country (2021–2032)
Figure 28. Germany Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Biosimilar Insulin Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Biosimilar Insulin Revenue Market Share by Region (2021–2032)
Figure 35. China Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Biosimilar Insulin Sales Market Share by Country (2021–2032)
Figure 45. Latin America Biosimilar Insulin Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Biosimilar Insulin Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Biosimilar Insulin Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Biosimilar Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Biosimilar Insulin by Type (2021–2032)
Figure 55. Global Revenue Market Share of Biosimilar Insulin by Type (2021–2032)
Figure 56. Global Biosimilar Insulin Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Biosimilar Insulin by Distribution Channel (2021–2032)
Figure 58. Global Revenue Market Share of Biosimilar Insulin by Distribution Channel (2021–2032)
Figure 59. Global Biosimilar Insulin Price (US$/Unit) by Distribution Channel (2021–2032)
Figure 60. Biosimilar Insulin Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
